Steven Cohen's ANIX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 17,276 shares of Anixa Biosciences, Inc. (ANIX) worth $44,572, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Steven Cohen has initiated a new position in ANIX, representing a fresh investment thesis on this company. Largest reduction occurred in Q1 2026, reducing 13,780 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Anixa Biosciences (ANIX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Anixa Biosciences (ANIX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -13,780 | Reduce 44.37% | 17,276 | $2.58 |
| Q4 2025 | +31,056 | New Buy | 31,056 | $3.12 |
Steven Cohen's Anixa Biosciences Investment FAQs
Steven Cohen first purchased Anixa Biosciences, Inc. (ANIX) in Q4 2025, acquiring 31,056 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Anixa Biosciences, Inc. (ANIX) for 2 quarters since Q4 2025.
Steven Cohen's largest addition to Anixa Biosciences, Inc. (ANIX) was in Q4 2025, adding 31,056 shares worth $96,895.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 17,276 shares of Anixa Biosciences, Inc. (ANIX), valued at approximately $44,572.
As of the Q1 2026 filing, Anixa Biosciences, Inc. (ANIX) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Anixa Biosciences, Inc. (ANIX) was 31,056 shares, as reported at the end of Q4 2025.